CGEM
Cullinan Oncology Inc

453
Mkt Cap
$722.5M
Volume
686,517.00
52W High
$13.43
52W Low
$5.68
PE Ratio
-3.32
CGEM Fundamentals
Price
$11.83
Prev Close
$12.23
Open
$12.16
50D MA
$11.15
Beta
1.14
Avg. Volume
685,600.45
EPS (Annual)
-$3.11
P/B
1.60
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Cullinan Therapeutics (NASDAQ:CGEM) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen downgraded Cullinan Therapeutics from a "hold" rating to a "sell" rating in a research note on Sunday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Reaches New 12-Month High - Time to Buy?
Cullinan Therapeutics (NASDAQ:CGEM) Reaches New 52-Week High - Here's Why...
MarketBeat·7d ago
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen raised Cullinan Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·10d ago
News Placeholder
Are Medical Stocks Lagging AIM ImmunoTech (AIM) This Year?
Here is how AIM ImmunoTech Inc. (AIM) and Cullinan Therapeutics (CGEM) have performed compared to their sector so far this year.
Zacks·13d ago
News Placeholder
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives Average Rating of "Moderate Buy" from Brokerages
Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) have earned an average recommendation of "Moderate Buy" from the eight research firms that are currently covering the stock...
MarketBeat·16d ago
News Placeholder
Here's What Could Help Cullinan Therapeutics (CGEM) Maintain Its Recent Price Strength
Cullinan Therapeutics (CGEM) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Zacks·18d ago
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Upgraded by Zacks Research to Strong-Buy Rating
Zacks Research raised Cullinan Therapeutics from a "hold" rating to a "strong-buy" rating in a research note on Wednesday...
MarketBeat·18d ago
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Trading Up 10.6% - Here's Why
Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Up 10.6% - Here's What Happened...
MarketBeat·18d ago
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Down 6.2% - Here's What Happened
Cullinan Therapeutics (NASDAQ:CGEM) Shares Down 6.2% - Should You Sell...
MarketBeat·28d ago
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Trading Up 3.9% - What's Next?
Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Up 3.9% - Here's Why...
MarketBeat·1mo ago
<
1
2
...
>

Latest CGEM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.